ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins Predicted intracellular proteins
| | ![](/images/34510/if_selected_60x60.jpg) | | ![](/images/9796/24747_B_1_7_rna_selected_60x60.jpg) | Group enriched |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | ![](/images/49117/1363_F2_2_selected_60x60.jpg) | | ![](/images/49117/110535_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
BIN2 | Bridging integrator 2 | Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/38667/106333_A_3_5_rna_selected_60x60.jpg) | Tissue enhanced |
BPI | Bactericidal/permeability-increasing protein | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/61284/143108_B_7_6_rna_selected_60x60.jpg) | Tissue enriched |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | ![](/images/1198/2772_A_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/6558/22094_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3796/11202_A_9_6_rna_selected_60x60.jpg) | Group enriched |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/8750/27531_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2420/6095_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2492/6131_A_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/43955/119468_A_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2497/6307_A_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD5 | CD5 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/20308/if_selected_60x60.jpg) | | ![](/images/15392/34316_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2503/6465_A_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD79A | CD79a molecule, immunoglobulin-associated alpha | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/19/395_A_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
CLC | Charcot-Leyden crystal galectin | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/41751/91966_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
CTSG | Cathepsin G | Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/47737/123206_B_8_8_rna_selected_60x60.jpg) | Tissue enriched |
CTSW | Cathepsin W | Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/16345/36106_B_6_3_rna_selected_60x60.jpg) | Tissue enhanced |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/8928/if_selected_60x60.jpg) | | ![](/images/2624/6433_A_9_8_rna_selected_60x60.jpg) | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1295/3239_A_3_3_rna_selected_60x60.jpg) | Group enriched |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | | ![](/images/232/654_A_9_7_rna_selected_60x60.jpg) | Tissue enriched |
HBQ1 | Hemoglobin, theta 1 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/62473/144087_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | ![](/images_static/na_center.gif) | | ![](/images/9247/32859_A_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/4723/if_selected_60x60.jpg) | | ![](/images/4458/14041_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2301/if_selected_60x60.jpg) | | ![](/images/13967/30400_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images/11157/if_selected_60x60.jpg) | | ![](/images/2223/5872_A_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/3494/if_selected_60x60.jpg) | | ![](/images/3816/10092_B_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
LCN2 | Lipocalin 2 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2695/8562_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
LEF1 | Lymphoid enhancer-binding factor 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | ![](/images/2087/if_selected_60x60.jpg) | | ![](/images/2087/7385_B_2_7_rna_selected_60x60.jpg) | Tissue enhanced |
LRMP | Lymphoid-restricted membrane protein | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | ![](/images/2967/9462_A_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
MKI67 | Marker of proliferation Ki-67 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | ![](/images/58/155452_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21147/146570_B_7_6_rna_selected_60x60.jpg) | Tissue enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/14341/39080_B_8_5_rna_selected_60x60.jpg) | Group enriched |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/47836/129864_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
NOS3 | Nitric oxide synthase 3 (endothelial cell) | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2168/5988_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
PAX5 | Paired box 5 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | | ![](/images/56394/140589_A_7_5_rna_selected_60x60.jpg) | Tissue enhanced |
PLEK | Pleckstrin | Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/31838/68854_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | | ![](/images/2513/6474_A_9_5_rna_selected_60x60.jpg) | Group enriched |
PPBP | Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/17624/40181_B_7_8_rna_selected_60x60.jpg) | Tissue enriched |
RASAL3 | RAS protein activator like 3 | Predicted intracellular proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | | ![](/images/43417/119259_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
RCSD1 | RCSD domain containing 1 | Predicted intracellular proteins
| | ![](/images/16597/if_selected_60x60.jpg) | | ![](/images/16597/39181_A_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
RENBP | Renin binding protein | Enzymes Predicted intracellular proteins
| | | | ![](/images/522/904_A_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
SASH3 | SAM and SH3 domain containing 3 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1085/2601_B_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
SEPT1 | Septin 1 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/41566/89971_A_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
SNCA | Synuclein, alpha (non A4 component of amyloid precursor) | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/10877/28531_B_6_7_rna_selected_60x60.jpg) | Tissue enhanced |
SPN | Sialophorin | CD markers Predicted membrane proteins
| | ![](/images/2666/if_selected_60x60.jpg) | | ![](/images/55244/134326_A_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | ![](/images/3394/10561_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
SRGN | Serglycin | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/759/1819_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
TCL1A | T-cell leukemia/lymphoma 1A | Cancer-related genes Disease related genes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/16604/37652_B_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | ![](/images/8380/if_selected_60x60.jpg) | | ![](/images/8380/19870_B_8_1_rna_selected_60x60.jpg) | Group enriched |